Explore the revolutionary bifunctional siRNA therapy that simultaneously targets TGF-β1 and activates RIG-I to combat pancreatic cancer's immunosuppressive defenses.
Discover how the EPHA2/COX-2 axis creates an immunosuppressive barrier in pancreatic cancer and the promising therapeutic approaches to overcome it.